Form 8-K

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): May 4, 2004

 


 

AMEDISYS, INC.

(Exact Name of Registrant as Specified in Charter)

 


 

Delaware

(State or Other Jurisdiction of

Incorporation or Organization)

 

0-24260   11-3131700
(Commission File Number)   (I.R.S. Employer Identification No.)

 

11100 Mead Road, Suite 300, Baton Rouge, LA 70816

(Address of principal executive offices including zip code)

 

(225) 292-2031

(Registrant’s telephone number, including area code)

 



ITEM 7.         FINANCIAL STATEMENTS AND EXHIBITS

 

(a)   Financial Statements of Business Acquired.
    Not applicable.
(b)   Pro Forma Financial Information.
    Not applicable.
(c)   Exhibit No.
    99.1 (i)   Press Release dated May 4, 2004 announcing the Company’s first quarter 2004 operating results
        (i) Filed herewith.

 

Item 12. Results of Operations and Financial Condition.

 

The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section. The information in this Current Report shall not be incorporated by reference into any registration statement or document pursuant to the Securities Act of 1933, as amended.

 

On May 4, 2004, Amedisys, Inc. issued a press release attached hereto as Exhibit 99.1 announcing its financial results for the first quarter of fiscal year 2004, which ended March 31, 2004.


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

AMEDISYS, INC.

By:

 

/s/    Gregory H. Browne


Gregory H. Browne

Chief Financial Officer

 

DATE: May 6, 2004